Las Tunas. – number of population Las Tunas Abdullah is aspiring to receive the candidate vaccine, which is currently in the clinical trials stage, according to Abdullah, according to a director Public Health In this province, Viviana Gutiérrez Rodríguez, vaccination against Covid-19 should take place in the second half of the year.
Gutierrez Rodriguez stressed that it should start in the municipality of Las Tunas, most affected by the disease, and in high-risk populations, although there is no specific date for this important measure.
Meanwhile, residents of this region are still waiting for the ongoing process of clinical trials of Cuban vaccine proposals, which are taking place in various provinces of the country with the participation of thousands of volunteers.
Las Tunas is one of the regions with the lowest prevalence of the epidemic, with 790 infections – 174 of them imported – and three deaths.
The group most affected by the disease is from 40 to 59 years old with 343 patients, followed by 243 between 20 and 39 years old, asymptomatic positives.
Maria Elena Soto Entinza, Head of the National Administration for Primary health care In Cuba, on the morning of April 22, 2021, it was determined that in May the application of the vaccine for candidates Soberana 02 and Abdala will begin in Havana, which has been hardest hit by the Covid-19 pandemic.
Abdallah and Sobrana will be implemented in seven Havana municipalities where there are currently no clinical trials.
The population intervention will start at the age of 19 and is organized by age groups, with priority given to people aged 60 and over who have the highest morbidity and mortality indicators for the epidemic. Immunization will continue for people between the ages of 40 and 59 and then in the rest of the population over the age of 19.
A Cuban Ministry of Public Health official insisted that there are elements that exclude vaccination, such as not compensating for an underlying chronic disease at the time the dose is applied, but that once the criteria are normalized, the patient can receive it.
Additionally, he said pregnant women, postpartum women, infants, and people who have contracted the Covid 19 virus are now excluded from vaccination, as they are customizing the Soberana Plus candidate vaccine.
Soto Entinza stressed the importance of compliance with one-hour post-vaccination monitoring, while ensuring that the process was organized for more than two months, with training in good clinical practices in municipalities and research teams designed for each health district. At the same time, they have syringes and all the necessary supplies.
At a higher rate, the vaccination will be in the offices of the family doctor and nurses and they plan to vaccinate more than 1,700,000 people.
This is a great moment for the Family Doctor and Nurse program (created by Fidel Castro at the end of 1983), and Soto Entinza appreciated.
The doctor stressed that vaccinations are not magic, they take some time, and as long as they do not spread to everyone, it is necessary to maintain measures aimed at self-protection.
Since March 22, intervention has started in high-risk groups, especially workers associated with the care of Covid patients, and coverage is recorded in more than 75,000 people with Superna 01. As of April 19, the second dose of this vaccine is given every 28 days, then 56.
Immunization will now be expanded to include universities of medicine and students associated with a direct investigation of Covid 19. This health worker protection process will then reach the rest of the country.
So far, Abdullahi candidate vaccine is being applied in the provinces of Santiago de Cuba, Guantanamo and Granma East, with 48,000 volunteers, and will start its second dose.
Cuba has five candidate vaccines in various stages of testing to immunize a population of more than 11 million, with nearly 100,000 infected with the new coronavirus more than a year after the epidemic.
Finlay Vaccine Institute, leader of Soberana 01, Soberana 02, Soberana Plus, and Center for Genetic Engineering and Biotechnology (CIGB), the developer of Mambesa, and Abdullah are the two centers responsible for the country’s leading biotechnology and vaccine products.
/ mga /